Trial Profile

A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED MULTICENTER TRIAL ON THE EFFICACY OF VARENICLINE AND BUPROPION, IN COMBINATION AND ALONE, FOR THE TREATMENT OF ALCOHOL USE DISORDER

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 11 Jun 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

08 May 2024 Primary endpoint has been met (Alcohol Consumption as Measured by Heavy Drinking Days (HDD)) , according to Results presented at the 177th Annual Meeting of the American Psychiatric Association
08 May 2024 Primary endpoint has been met (Alcohol Consumption as Measured by Phosphatidylethanol (PEth) in Blood) , according to Results presented at the 177th Annual Meeting of the American Psychiatric Association
08 May 2024 Results presented at the 177th Annual Meeting of the American Psychiatric Association

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com